A Pilot Safety Study of Vaccination With Autologous, Lethally Irradiated Colorectal Cancer Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Human Granulocyte-Macrophage Stimulating Factor
Phase of Trial: Phase I
Latest Information Update: 21 Nov 2016
At a glance
- Drugs Tumour cell vaccine-GVAX (Primary)
- Indications Colorectal cancer; Liver metastases
- Focus Adverse reactions
- 07 Jun 2017 Biomarkers information updated
- 17 Nov 2016 Planned primary completion date changed from 1 Jul 2015 to 1 Jul 2018.
- 17 Nov 2016 Planned End Date changed from 1 Jul 2025 to 1 Jul 2030.